Brownlee et al., 1983 - Google Patents
Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.Brownlee et al., 1983
View PDF- Document ID
- 16321071465967851950
- Author
- Brownlee M
- Pongor S
- Cerami A
- Publication year
- Publication venue
- The Journal of experimental medicine
External Links
Snippet
The chronic tissue damage associated with long-term diabetes mellitus may arise in part from in situ immune complex formation by accumulated immunoglobulins and/or antigens bound to long-lived structural proteins that have undergone excessive nonenzymatic …
- 102000004169 proteins and genes 0 title abstract description 38
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brownlee et al. | Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes. | |
US4900747A (en) | Method and agents for removing advanced glycosylation endproducts | |
Williams et al. | Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable. | |
Price et al. | Studies on the metabolism of the renal glomerular basement membrane. Turnover measurements in the rat with the use of radiolabeled amino acids | |
Duckworth et al. | Purification of insulin-specific protease by affinity chromatography | |
Rizzetto et al. | Types ofreticulin'antibodies detected in human sera by immunofluorescence | |
US5202424A (en) | Mesangial cell-derived receptors for advanced glycosylation endproducts and uses thereof | |
US5238963A (en) | Method and agents for inhibiting protein aging | |
Spiegelberg et al. | Catabolism of human γG-immunoglobulins of different heavy chain subclasses: I. Catabolism of γG-myeloma proteins in man | |
JPH07503713A (en) | Amino acids useful as protein hyperglycosylation inhibitors | |
US3847890A (en) | Acidic monosaccharide-substituted proteins | |
Sankaran et al. | Insulin action in pancreatic acini from streptozotocin-treated rats. II. Binding of 125I-insulin to receptors | |
Nakatani et al. | Effects of parathyroid hormone on cAMP production and alkaline phosphatase activity in osteoblastic clone MC3T3-E1 cells | |
EP0259893A2 (en) | Agents for removing advanced glycosylation endproducts | |
JPH03103163A (en) | Deterioration-preventing agent for food | |
Brown et al. | Studies of the mechanism of iron absorption. I. Iron uptake by the normal rat | |
JPH09508130A (en) | Use of BPI protein products in human therapy Cross-reference of relevant applications | |
Chisari | Regulation of human lymphocyte function by a soluble extract from normal human liver | |
JP3579549B2 (en) | Use as a marker for diabetes or diabetic complications | |
US6114323A (en) | Methods for inhibiting the advanced glycosylation of proteins | |
Davis III et al. | Homozygous C3 deficiency: detection of C3 by radioimmunoassay | |
CHENOWETH | Complement mediators of inflammation | |
Budzynski et al. | Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood | |
Osserman et al. | The plasma proteins in liver disease | |
BROWNLEE et al. | Role in the In Situ Formation of Immune Complexes |